| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |